The impact of microbials on gonococcal evolution
Leonor Sánchez-Busó 1, Daniel Golparian2, Jukka Corander1,3,4, Yonatan H. Grad 5,6, Makoto Ohnishi7,8, Rebecca Flemming9, Julian Parkhill 1, Stephen D. Bentley1, Magnus Unemo2 and Simon R. Harris 1*,
MetadataShow full item record
Flemming, R., & Leonor Sánchez-Busó 1, D. G. J. C. Y. H. G. 5. M. O. R. F. J. P. 1. S. D. B. M. U. a. S. R. H. 1. (2019). The impact of microbials on gonococcal evolution. Nature Microbiology https://doi.org/10.1038/s41564-019-0501-y
The sexually transmitted pathogen Neisseria gonorrhoeae is regarded as being on the way to becoming an untreatable superbug. Despite its clinical importance, little is known about its emergence and evolution, and how this corresponds with the introduction of antimicrobials. We present a genome-based phylogeographical analysis of 419 gonococcal isolates from across the globe. Results indicate that modern gonococci originated in Europe or Africa, possibly as late as the sixteenth century and subsequently disseminated globally. We provide evidence that the modern gonococcal population has been shaped by antimicrobial treatment of sexually transmitted infections as well as other infections, leading to the emergence of two major lineages with different evolutionary strategies. The well-described multidrug-resistant lineage is associated with high rates of homologous recombination and infection in high-risk sexual networks. A second, multisusceptible lineage is more associated with heterosexual networks, with potential implications for infection control.
This work was funded by the Wellcome grant number 098051 and the Foundation for Medical Research at Örebro University Hospital, Örebro, Sweden. J.C. was funded by the ERC grant number 745258. Y.H.G. is supported by The Smith Family Foundation and the NIH/NIAID grant 1R01AI132606-01.
External DOI: https://doi.org/10.1038/s41564-019-0501-y
This record's URL: https://www.repository.cam.ac.uk/handle/1810/296384
All rights reserved